Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 208

1.

Clinical endocrinology and metabolism. Glucagon-like peptide-1 and glucagon-like peptide-2.

Baggio LL, Drucker DJ.

Best Pract Res Clin Endocrinol Metab. 2004 Dec;18(4):531-54. Review.

PMID:
15533774
2.

Glucagon-like peptides.

Drucker DJ.

Diabetes. 1998 Feb;47(2):159-69. Review.

PMID:
9519708
3.

Biological actions and therapeutic potential of the glucagon-like peptides.

Drucker DJ.

Gastroenterology. 2002 Feb;122(2):531-44. Review.

PMID:
11832466
4.

Is glucagon-like peptide 1 an incretin hormone?

Nauck MA.

Diabetologia. 1999 Mar;42(3):373-9. Review.

PMID:
10096792
5.

[Glucagon-like peptides--synthesis, biological actions and some clinical implications].

Otto Buczkowska E, Dworzecki T.

Przegl Lek. 2004;61(9):947-50. Review. Polish.

PMID:
15803906
6.

GLP-1 in NIDDM.

Holst JJ.

Diabet Med. 1996 Sep;13(9 Suppl 6):S156-60. Review.

PMID:
8894501
7.

The physiological role of GLP-1 in human: incretin, ileal brake or more?

Schirra J, Göke B.

Regul Pept. 2005 Jun 15;128(2):109-15. Review.

PMID:
15780430
8.
9.

Glucagon-like peptide 1 agonists and the development and growth of pancreatic beta-cells.

List JF, Habener JF.

Am J Physiol Endocrinol Metab. 2004 Jun;286(6):E875-81. Review.

10.

Harnessing the therapeutic potential of glucagon-like peptide-1: a critical review.

Baggio LL, Drucker DJ.

Treat Endocrinol. 2002;1(2):117-25. Review.

PMID:
15765627
13.

Glucagon-like peptide-1(7-37)/(7-36)amide is a new incretin.

Fehmann HC, Göke R, Göke B.

Mol Cell Endocrinol. 1992 May;85(1-2):C39-44. Review.

PMID:
1382025
14.

The multiple actions of GLP-1 on the process of glucose-stimulated insulin secretion.

MacDonald PE, El-Kholy W, Riedel MJ, Salapatek AM, Light PE, Wheeler MB.

Diabetes. 2002 Dec;51 Suppl 3:S434-42. Review.

15.

Incretin hormones--an update.

Holst JJ, Orskov C.

Scand J Clin Lab Invest Suppl. 2001;234:75-85. Review.

PMID:
11713984
16.

Glucagon-like peptide 1(GLP-1) in biology and pathology.

Meier JJ, Nauck MA.

Diabetes Metab Res Rev. 2005 Mar-Apr;21(2):91-117. Review.

PMID:
15759282
17.

Nutrient, neural and endocrine control of glucagon-like peptide secretion.

Dubé PE, Brubaker PL.

Horm Metab Res. 2004 Nov-Dec;36(11-12):755-60. Review.

PMID:
15655704
18.

Glucagon-like peptide 1 as a regulator of food intake and body weight: therapeutic perspectives.

Meier JJ, Gallwitz B, Schmidt WE, Nauck MA.

Eur J Pharmacol. 2002 Apr 12;440(2-3):269-79. Review.

PMID:
12007541
19.

Glucagon-like peptide 1: evolution of an incretin into a treatment for diabetes.

D'Alessio DA, Vahl TP.

Am J Physiol Endocrinol Metab. 2004 Jun;286(6):E882-90. Review.

20.

The incretins: a link between nutrients and well-being.

Burcelin R.

Br J Nutr. 2005 Apr;93 Suppl 1:S147-56. Review.

PMID:
15877888

Supplemental Content

Support Center